Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: InDi Hires Bencich and Tonachio

Premium

Integrated Diagnostics has appointed John Bencich as chief financial officer and Jill Tonachio as vice president for sales.

Bencich most recently served as the CFO of Allozyne. Prior to that, he was vice president, chief financial officer, and treasurer of Trubion Pharmaceuticals until its acquisition by Emergent BioSolutions. Before that he was the director of finance and corporate controller for Onyx Software. He holds a BA in accountancy from the University of San Diego and an MBA from Seattle University.

Tonachio was most recently national director of sales for Aurora Diagnostics. She has also held sales positions at Aureon Laboratories, Laboratory Corporation of America, Dianon Systems, and Johnson & Johnson. She holds a BS in business logistics from Pennsylvania State University.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.